Medtech Startup in India

939 views
758 views

Published on

Describes the journey of a medtech startup in India. Talks about different stages of Idea generation to Validation to Market and funding opportunities for each stage. Presentation given to students, entrepreneurs at various forums by CEO.

Published in: Health & Medicine
0 Comments
2 Likes
Statistics
Notes
  • Be the first to comment

No Downloads
Views
Total views
939
On SlideShare
0
From Embeds
0
Number of Embeds
27
Actions
Shares
0
Downloads
0
Comments
0
Likes
2
Embeds 0
No embeds

No notes for slide

Medtech Startup in India

  1. 1. Medtech Startup in India idea to market Leo Mavely CEO Axio Biosolutions Pvt. Ltd.
  2. 2. Entrepreneurship = Marriage
  3. 3. FLIRTDATEPROPOSEMARRY
  4. 4. FLIRT
  5. 5. Identify: Unmet need Basket of solutions Technology IDEA
  6. 6. DATE
  7. 7. Evaluate: • Freedom to Operate IP • Potential to Patent • Tech transfer • Current usage Market • Trends • Classification & Compliance Regulatory • Safety, Efficacy, Consistency • ISO, IP/EP/UP, ASTM, FDA, MDD
  8. 8. PROPOSE
  9. 9. Proof of concept Initial prototypes • Tested • Patent filing Market • Potential customers • Suppliers Execution strategy • Business Plan • Core team
  10. 10. MARRY
  11. 11. Start-up • Register a company • Compliance • Recruitment • Institutional funds • MARKET
  12. 12. Funding Avenues FLIRT, DATE, PROPOSE • Boot strap – Family / Friends / Fools • Incubation funds • Govt. schemes - SBIRI, TePP, BIPP, MSME • Angels / HNIs MARRY • Venture Capital, PE • Banks (eg: CGTMSE) • Licensing / SBUs
  13. 13. OUR JOURNEY
  14. 14. Axio Biosolutions• Started as incubated project in ’07 at NirmaLabs• Focus areas: Biomaterial based woundcare – Hemostasis – Infection control – Wound healing• axiostat – India’s First Emergency hemostat.
  15. 15. DEATH DUE TO TRAUMATraumatic Bleeding Civilian -- 42% CNS Military -- 47% Hemorrhage -- 39% Hemorrhage -- 36% CNS -- 12% Multiple -- 13% Multiple -- 7% MOF -- 4% MOF Sauaia et al. J Trauma 1995:38; 185-192 Bellamy RF. Mil Med 1984: 149: 55-62 15
  16. 16. Stops profuse bleeding within minutesMade of natural biomaterialsNon-toxic, BiocompatibleApplications: Lacerations, Abrasions,Punctures, Arterial/venous ruptures,Intravascular ProceduresEffective for coagulopathic victimsDurable – 3 yrs Shelf life **Trademark under registration 16 * Patent Pending
  17. 17. Timeline 2007 - Incubation & Product dev. starts 2008 - Proof of concept - Axio Biosolutions Pvt. Ltd. established - Provisional patent filed 2009 - Preclinical safety studies - Preclinical efficacy study - MSME Foundation grant 2010 - Complete patent filed - GMP Manufacturing - Regulation approval submission - VC Investment 2011 - Clinical studies 2012 - Regulatory clearance for mfg and marketing
  18. 18. Keep‘em Open
  19. 19. Plan Organize
  20. 20. Create aTeam
  21. 21. Take that big step forward…
  22. 22. leo.mavely@gmail.com twitter.com/4eo

×